🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparison Between Transarterial Musculoskeletal Embolization and Platelet-Rich Plasma Injection for the Treatment of Greater Trochanteric Pain Syndrome

RecruitingPhase 2Ages 18 Years - 80 YearsAllUnidade Local de Saúde do Alto Ave, EPE
NCT07396246 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Greater Trochanteric Pain Syndrome (GTPS) is a common cause of lateral hip pain that can significantly affect daily activities and quality of life. Standard treatments include physical therapy, anti-inflammatory medications, and local injections, but many patients continue to experience persistent symptoms. This randomized controlled trial aims to compare two minimally invasive treatment options for GTPS: transarterial musculoskeletal embolization (TAME) and platelet-rich plasma (PRP) injection. Participants will be randomly assigned to receive either TAME or PRP. The main goal of the study is to evaluate which treatment is more effective in reducing pain. Secondary goals include comparing functional improvement, quality of life, and safety between the two treatments. Pain and functional outcomes will be assessed at baseline and during follow-up at 1, 3, 6, and 12 months after treatmen

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosis of GTPS confirmed by clinical and imaging assessments * Persistent symptoms despite at least 3 months of conservative treatment (e.g., physical therapy, NSAIDs) * Willingness to participate and provide informed consent * Availability for follow-up assessments at 1, 3, 6, and 12 months post-treatment Exclusion Criteria: * Prior hip surgery or other interventions (e.g., joint replacement, prior PRP injections or embolization) * Severe osteoarthritis (Tonnis III) * Active lumbar radiculopathy with pain, numbness, or weakness in a dermatomal distribution * Contraindications for PRP injections (e.g., active infection, coagulopathy, antiplatelet or anticoagulation therapy, * Pregnancy or breastfeeding * Severe comorbidities that would interfere with participation * Active cancer or other malignancies
💊

What it tests

  • Transarterial Musculoskeletal Embolization
  • Platelet-Rich Plasma Injection
📍

Where

1 site
Unidade Local de Saúde do Alto Ave
Guimarães, Portugal
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy